文献速递糖尿病

急性高血糖对1型糖尿病年轻人运动表现无一致不良影响:随机交叉临床研究

Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study.
PubMed 文献 · Diabetologia · 2021-05-04

本研究在12名无并发症的1型糖尿病年轻人中,采用三种钳夹条件(正常血糖+高胰岛素、高血糖+高胰岛素、高血糖+低胰岛素)进行随机交叉试验,评估急性高血糖对运动表现的影响。主要结局显示,高胰岛素状态下急性高血糖使摄氧量轻微降低,但低胰岛素状态下无差异;冲刺功率和反应时间呈现胰岛素依赖性的不同方向变化。结论认为急性高血糖并非一致有害,对休闲活动个体的整体运动表现无临床相关损害。

要点

  • 高胰岛素状态下急性高血糖使摄氧量轻微降低(差异0.17 l/min,p=0.02),低胰岛素状态无差异。
  • 高血糖+低胰岛素状态下冲刺峰值功率更高(+64 W,p=0.02),但简单反应时间更慢(+11 ms,p=0.04)。
  • 急性高血糖对运动表现的影响不一致,整体无临床相关损害。

核心结论

  • 急性显著高血糖在高胰岛素状态下轻微损害摄氧量,但低胰岛素状态无此影响。
  • 急性高血糖对冲刺功率和反应时间的影响呈胰岛素依赖性且方向相反,对其他运动表现指标无影响。
  • 急性高血糖并非一致有害,对休闲活动1型糖尿病个体的整体运动表现无临床相关损害。

研究设计与样本

  • 随机交叉临床研究,纳入12名14-30岁无并发症、HbA1c≤75 mmol/mol(≤9%)的1型糖尿病休闲活动个体。
  • 受试者在三个独立日接受钳夹试验:正常血糖(5 mmol/l)加20 mU [m2 BSA]-1 min-1胰岛素(Eu20)、高血糖(17 mmol/l)加20 mU [m2 BSA]-1 min-1胰岛素(Hyper20)、高血糖(17 mmol/l)加5 mU [m2 BSA]-1 min-1胰岛素(Hyper5)。
  • 主要结局为摄氧量差异,并评估冲刺骑行、握力、平衡、跳跃、反应时间等指标。

主要发现

  • 与Eu20相比,Hyper20的摄氧量较低(差异0.17 l/min [95% CI 0.31, 0.04; p=0.02],为Eu20均值的6.6%),Hyper5无差异(p=0.39)。
  • 与Eu20相比,Hyper20冲刺峰值功率无差异(p=0.20),Hyper5更高(64 W [95% CI 13, 115; p=0.02],13.1%)。
  • 与Eu20相比,Hyper20简单反应时间无差异(p=0.12),Hyper5更慢(11毫秒 [95% CI 1, 22; p=0.04],4.7%)。
  • 其他测试指标在Eu20与两种高血糖条件间均无差异(p>0.05)。

临床怎么用

  • 对于休闲活动的1型糖尿病年轻人,急性高血糖不应成为阻止运动的理由,但高胰岛素状态下需注意摄氧量可能轻微下降。
  • 高血糖伴低胰岛素时冲刺功率可能提高但反应时间减慢,运动类型和胰岛素状态需个体化考量。

局限性

  • 样本量小(12人),仅限休闲活动且无并发症的年轻1型糖尿病患者。
  • 研究为急性钳夹试验,结果不能外推至长期血糖控制或竞技运动员。
  • 部分运动表现指标未显示差异,可能受样本量和检测灵敏度限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: In individuals with type 1 diabetes, chronic hyperglycaemia impairs aerobic fitness. However, the effect of acute marked hyperglycaemia on aerobic fitness is unclear, and the impact of insulin level has not been examined. In this study, we explored if acute hyperglycaemia with higher or low insulin levels affects [Formula: see text] and other exercise performance indicators in individuals with type 1 diabetes. METHODS: Eligible participants were aged 14 to 30 years, with complication-free, type 1 diabetes and HbA1c ≤ 75 mmol/mol (≤9%). Participants exercised in a clinical laboratory under three clamp (constant insulin, variable glucose infusion) conditions: euglycaemia (5 mmol/l) with 20 mU [m2 BSA]-1 min-1 insulin (where BSA is body surface area) (Eu20); hyperglycaemia (17 mmol/l) with 20 mU [m2 BSA]-1 min-1 insulin (Hyper20); and hyperglycaemia (17 mmol/l) with 5 mU [m2 BSA]-1 min-1 insulin (Hyper5) on separate days. Participants and the single testing assessor were blinded to condition, with participants allocated to randomised testing condition sequences as they were consecutively recruited. Standardised testing (in order) conducted on each of the three study days included: triplicate 6 second sprint cycling, grip strength, single leg static balance, vertical jump and modified Star Excursion Balance Test, ten simple and choice reaction times and one cycle ergometer [Formula: see text] test. The difference between conditions in the aforementioned testing measures was analysed, with the primary outcome being the difference in [Formula: see text]. RESULTS: Twelve recreationally active individuals with type 1 diabetes (8 male, mean ± SD 17.9 ± 3.9 years, HbA1c 61 ± 11 mmol/mol [7.7 ± 1.0%], 7 ± 3 h exercise/week) were analysed. Compared with Eu20, [Formula: see text] was lower in Hyper20 (difference 0.17 l/min [95% CI 0.31, 0.04; p = 0.02] 6.6% of mean Eu20 level), but Hyper5 was not different (p = 0.39). Compared with Eu20, sprint cycling peak power was not different in Hyper20 (p = 0.20), but was higher in Hyper5 (64 W [95% CI 13, 115; p = 0.02] 13.1%). Hyper20 reaction times were not different (simple: p = 0.12) but Hyper5 reaction times were slower (simple: 11 milliseconds [95% CI 1, 22; p = 0.04] 4.7%) than Eu20. No differences between Eu20 and either hyperglycaemic condition were observed for the other testing measures (p > 0.05). CONCLUSIONS/INTERPRETATION: Acute marked hyperglycaemia in the higher but not low insulin state impaired [Formula: see text] but to a small extent. Acute hyperglycaemia had an insulin-dependent effect on sprint cycling absolute power output and reaction time but with differing directionality (positive for sprint cycling and negative for reaction time) and no effect on the other indicators of exercise performance examined. We find that acute hyperglycaemia is not consistently adverse and does not impair overall exercise performance to an extent clinically relevant for recreationally active individuals with type 1 diabetes. FUNDING: This research was funded by Diabetes Research Western Australia and Australasian Paediatric Endocrine Group grants.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Rothacker KM, Armstrong S, Smith GJ, et al. Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study. Diabetologia. 2021. PMID: 33944971. doi:10.1007/s00125-021-05465-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。